Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 23;13(7):1211.
doi: 10.3390/diagnostics13071211.

Current Concepts of Precancerous Lesions of Hepatocellular Carcinoma: Recent Progress in Diagnosis

Affiliations
Review

Current Concepts of Precancerous Lesions of Hepatocellular Carcinoma: Recent Progress in Diagnosis

Ziyue Liao et al. Diagnostics (Basel). .

Abstract

The most common cause of hepatocellular carcinoma (HCC) is chronic hepatitis and cirrhosis. It is proposed that precancerous lesions of HCC include all stages of the disease, from dysplastic foci (DF), and dysplastic nodule (DN), to early HCC (eHCC) and progressed HCC (pHCC), which is a complex multi-step process. Accurately identifying precancerous hepatocellular lesions can significantly impact the early detection and treatment of HCC. The changes in high-grade dysplastic nodules (HGDN) were similar to those seen in HCC, and the risk of malignant transformation significantly increased. Nevertheless, it is challenging to diagnose precancerous lesions of HCC. We integrated the literature and combined imaging, pathology, laboratory, and other relevant examinations to improve the accuracy of the diagnosis of precancerous lesions.

Keywords: biomarkers; diagnostic imaging; hepatocellular carcinoma; pathology; precancerous conditions.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Histological characterization of hepatic cirrhosis (A), low-grade dysplastic nodule (LGDN) (B), high-grade dysplastic nodule (HGDN) (C), and early hepatocellular carcinoma (eHCC) (D). In cirrhosis, the normal lobular structure is destroyed and replaced by pseudolobules. The arrangement of hepatocytes in the pseudolobules is disturbed, accompanied by degeneration, necrosis, and regeneration of hepatocytes, and the central vein is often absent (A); LGDN is mainly characterized by macrocell dysplasia, with slightly increased density, portal structure, and no isolated arterioles of the pseudo glandular duct (B); HGDN is dominated by small cells with moderate to severe dysplasia, accompanied by structural dysplasia, and the cell arrangement density was significantly increased compared with the surrounding liver tissue (C); eHCC cell atypia is obvious, the cancer cells are different in size and shape, and the cancer cells are arranged in nests, with more of an interstitium (D). Note: Hematoxylin-esion staining, Magnification ×100 (A) and ×200 (BD).
Figure 2
Figure 2
(A) Early hepatocellular carcinoma (eHCC); (B) dysplastic nodule (DN); (C) hepatic cirrhosis regenerative nodule (RN). In a gadolinium ethoxylate disodium-enhanced MRI, eHCC only showed hyperintensity in the arterial phase, while in the T1W1 plain scan, the delayed phase and hepatobiliary phase had slight hypointensity or hypointensity to the adjacent liver (A); DN appeared to have slight hyperintensity on a T1W1 plain scan in the arterial phase, showing isointensity to the adjacent liver in the delayed phase, and showing hypointensity to the adjacent liver in the hepatobiliary phase (B); regenerative nodules (RNs) were shown to have slight hyperintensity on a T1W1 plain scan in the arterial phase, appearing to have isointensity or slight hypointensity to the adjacent liver in the delayed phase, and having isointensity to the adjacent liver in the hepatobiliary phase (C).

Similar articles

Cited by

References

    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Ojima H., Masugi Y., Tsujikawa H., Emoto K., Fujii-Nishimura Y., Hatano M., Kawaida M., Itano O., Kitagawa Y., Sakamoto M. Early hepatocellular carcinoma with high-grade atypia in small vaguely nodular lesions. Cancer Sci. 2016;107:543–550. doi: 10.1111/cas.12893. - DOI - PMC - PubMed
    1. Coral G.P., Branco F., Meurer R., Marcon P.D.S., Fontes P.R.O., de Mattos A.A. Results of immunohistochemistry in the differential diagnosis of early hepatocellular carcinoma and nodules with high-grade dysplasia in patients with cirrhosis. Arq. Gastroenterol. 2021;58:82–86. doi: 10.1590/s0004-2803.202100000-14. - DOI - PubMed
    1. Earl T.M., Chapman W.C. Hepatocellular Carcinoma: Resection versus Transplantation. Semin. Liver Dis. 2013;33:282–292. doi: 10.1055/s-0033-1351783. - DOI - PubMed
    1. Terminology of nodular hepatocellular lesions. Hepatology. 1995;22:983–993. doi: 10.1002/hep.1840220341. - DOI - PubMed

LinkOut - more resources